Journal article

The utility and limitations of 18F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: Single institution experience and literature review

CY Cheah, MS Hofman, JF Seymour, DS Ritchie, M Dickinson, A Wirth, HM Prince, M Wolf, EH Januszcewicz, DA Carney, KE Herbert, SJ Harrison, KL Burbury, CS Tam

Leukemia and Lymphoma | Published : 2015

Abstract

There are limited data regarding the role of 18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG PET-CT) scanning in primary mediastinal B-cell lymphoma (PMBL). We analyzed 28 patients with PMBL treated with chemotherapy, of whom 25 (89%) also received rituximab and 17 (61%) radiotherapy. PET-CT scans were interpreted using visual analysis and a 5-point scale. After a median follow-up of 2.6 years, four patients relapsed and two died. The 2-year progression-free survival and overall survival were 86% and 94%. PET-CT has excellent negative predictive value (interim, 86-87%; end of treatment, 95%) but limited positive predictive value due to the high frequency of ..

View full abstract